RCKT — Rocket Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $251.38m
- -$11.09m
Rocket Pharmaceuticals withdraws US application for blood disorder gene therapy (updated)
Rocket Pharmaceuticals withdraws US application of gene therapy for rare blood disorder
U.S. STOCKS ON THE MOVE- Shoe Carnival, Leidos Holdings, copper miners
U.S. STOCKS ON THE MOVE- Gap, Aquestive Therapeutics, Lumentum
U.S. STOCKS ON THE MOVE-Bruker Corp, Centuri Holdings, Shoe Carnival
US FDA program favorable for rare disease drug developers, says Jefferies
U.S. STOCKS ON THE MOVE-Dayforce, gold miners, Regeneron
U.S. STOCKS ON THE MOVE-Snowflake, silver miners, oil firms
Rocket Pharmaceuticals rises after FDA lifts clinical hold on gene therapy trial
U.S. STOCKS ON THE MOVE-Hertz, Analog Devices, TJX Companies
Brief: Rocket Pharmaceuticals Announces FDA Has Lifted The Clinical Hold On The Pivotal Phase 2 Trial Of Rp-A501 For The Treatment Of Danon Disease
U.S. STOCKS ON THE MOVE-Lowe's, Nu Holdings, Figma
US FDA lifts clinical hold on Rocket Pharmaceuticals' gene therapy trial (updated)
Rocket Pharmaceuticals rises after FDA lifts clinical hold on gene therapy trial
US FDA lifts clinical hold on Rocket Pharmaceuticals' gene therapy trial
Rocket Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Rocket Pharma Q2 net loss narrows; co cuts 30% of workforce
U.S. STOCKS ON THE MOVE-Eaton, Karman, Mobileye Global
U.S. STOCKS ON THE MOVE-Labcorp, Blackstone, L3Harris